Skip to main content
Erika (Hedderick) Finanger, MD, Child Neurology, Portland, OR

ErikaLee(Hedderick)FinangerMD

Child Neurology Portland, OR

Assistant Professor

Dr. Finanger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Finanger's full profile

Already have an account?

  • Office

    3181 Sw Sam Jackson Park Rd
    Cdrc-P
    Portland, OR 97239
    Phone+1 503-494-5856
    Fax+1 503-494-2370

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Neuromuscular Medicine (Neurology), 2008 - 2009
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Child Neurology, 2005 - 2008
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 2003

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2009 - 2025
  • WA State Medical License
    WA State Medical License 2023 - 2025
  • MD State Medical License
    MD State Medical License 2008 - 2010
  • MN State Medical License
    MN State Medical License 2004 - 2005
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Local Girl Receives First at-Home Treatment for Rare Disease
    Local Girl Receives First at-Home Treatment for Rare DiseaseNovember 13th, 2020
  • Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress
    Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business ProgressMay 12th, 2020
  • Edasalonexent May Limit Disease Progression in Boys with Duchenne MD, Phase 1/2 Trial Shows
    Edasalonexent May Limit Disease Progression in Boys with Duchenne MD, Phase 1/2 Trial ShowsMarch 1st, 2019
  • Join now to see all